Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Direct-From-Specimen Pneumonia Test Detects Pathogens and Resistance in Hours

By LabMedica International staff writers
Posted on 19 Nov 2026

Pneumonia is a leading cause of sepsis and is associated with high mortality. More...

Conventional culture-based pathogen identification and antimicrobial susceptibility testing can take two to four days, delaying information needed to guide antibiotic treatment. A new direct-from-specimen bacterial identification and susceptibility testing panel is now being evaluated in U.S. clinical microbiology laboratories to deliver results within hours.

Pattern Bioscience’s Pneumonia ID/AST Panel is being evaluated at five clinical microbiology laboratories across the United States through the company’s Early Evaluation Program. The panel is designed to support pneumonia diagnosis by identifying the organism causing infection and determining which antibiotics are likely to be effective. It provides bacterial detection, pathogen identification, and antimicrobial susceptibility testing in a single assay performed directly from lower respiratory tract specimens.

The assay runs on Pattern’s single-cell microbiology platform, a rapid phenotypic testing system designed for direct-from-specimen analysis. The platform is intended to deliver results within hours rather than the days typically required by conventional culture-based methods. Through the Early Evaluation Program, laboratory directors, medical laboratory scientists, and clinical partners can gain hands-on experience with the system in their own laboratories while providing feedback on workflow, integration pathways, and usability.

The Pneumonia ID/AST Panel has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). Subject to FDA clearance, Pattern plans to introduce the Pneumonia ID/AST Panel as its first commercial product.

“We appreciate the partnership of our early evaluation sites. Through these collaborations, we will continue to learn how laboratories will integrate the Pattern system into their routine workflow, and we will generate additional data to help quantify the potential impact of the platform,” said Carey-Ann Burnham, PhD, Chief Executive Officer.

Related Links
Pattern Bioscience


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Led by Professor Sherry Chan Kit-wa (middle), the HKUMed research team provides the first large-scale Chinese population evidence to support reviewing Hong Kong’s long-term blood-monitoring requirements for clozapine use. (Photo courtesy of HKUMed)

Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.